Search

You searched for "tear"

2488 results found

Surgitrac is proud to announce Jeremy Whitehouse as our new Clinical Representative for the Southwest region

14 May 2024 | Recruitment & Personnel
With over twelve years of hands-on experience in ophthalmic surgical scrub roles, as well as ENT and maxillofacial surgery, Jeremy brings a wealth of knowledge and understanding of surgical needs to our team.

Surgitrac Instruments is pleased to welcome back Scott Shipley as our new Clinical Representative for the Midlands region.

10 December 2024 | Company Profiles, Recruitment & Personnel
Sugitac Instruments is delighted to announce the addition of Scott Shipley as our new Clinical Representative for the Midlands region. Scott brings a strong passion for ophthalmology, a dedication to client relations, and a wealth of expertise that make him...

Mainline Instruments Appoints Jeff Landucci as Commercial Director - Ophthalmic Therapeutics

27 February 2025 | Recruitment & Personnel
Mainline Instruments is pleased to announce the appointment of Jeff Landucci as its new Commercial Director of Ophthalmic Therapeutics, effective February 28, 2025. Well known industry veteran, Landucci will join the senior management team and play a key role in...

Thinking about purchasing your first Volk lens or looking to expand your collection?

5 August 2025 | Company Profiles, Contracts & Distributors
Sister companies Altomed and Mid-Optic are proud to be official Volk distributors. With over 40 years of experience, our expert team can offer personalised guidance to help you choose the right lens for you. In addition, when you buy from...

Birmingham Optical Achieves UKAS ISO 9001 Certification

5 August 2025 | Company Profiles, Awards, Conferences & Anniversaries
Birmingham Optical, a leading UK provider of optical equipment and services, has been awarded the prestigious UKAS ISO 9001 certification, a globally recognised standard for quality management systems (QMS). This milestone reflects the company’s dedication to excellence, consistency, and customer...

A helping hand from Altomed

11 December 2025 | Company Profiles, Research & Development
Your training journey is important and Altomed is here to help you build skills with confidence. That’s why, for a short time only, we’re offering a Buy 2, Get 1 Free promotion on 4 SimulEYE models (see website for full...

Altomed is thrilled to announce the sponsorship of its 2nd Guide Dog puppy Geordie!

11 December 2025 | Company Profiles
Named in tribute to Altomed’s Northeast roots, Geordie is a striking black German Shepherd, confident, clever, and full of character. His unique breed makes him extra special within the Guide Dogs community. Geordie follows in the pawprints of Altomed’s first...

Raphaél Ervinckx joins Glaukos

11 December 2025 | Recruitment & Personnel
Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth. Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as...

Mainline Instruments at 100%

26 January 2026 | Company Profiles, Awards, Conferences & Anniversaries
Visit Mainline Instruments at STAND J20 during 100% Optical 2026 for an exciting programme of interactive workshops and expert-led lectures on the latest eye care innovations. Highlights include Ultra-Widefield Confocal Imaging, Dry Eye assessment, Tomography, and more. Don’t miss our...

Moorfields Education: New to Ophthalmology programme

25 March 2026 -27 March 2026
Moorfields Education: New to Ophthalmology programme

Rb-NET: a network to save life and preserve vision in children in Africa

1 April 2018 | | EYE - Pathology, EYE - Oncology
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...

Regulatory drug evaluations and expedited review initiatives: EU and US perspectives

1 April 2016 | | EYE - General
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...